ONWARD MEDICAL NV | WebDisclosure

Basculer en Français

10966	Companies
240147	Keywords
168916	Articles
129236	Press releases

Home
Companies
ONWARD MEDICAL NV

BRIEF

published on 09/09/2026 at 07:44, 3 days 21 hours ago

ONWARD Medical annonce une forte croissance au premier semestre 2026

Résultats Financiers Croissance Des Revenus ONWARD Medical Système ARC-EX Thérapie ARC
BRIEF

published on 09/09/2026 at 07:44, 3 days 21 hours ago

ONWARD Medical Reports Robust Growth in First Half of 2026

Financial Results Revenue Growth ONWARD Medical ARC-EX System ARC Therapy
PRESS RELEASE

published on 09/09/2026 at 07:39, 3 days 21 hours ago

ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
ONWARD Medical reports strong first half 2026 results with robust revenue growth and pipeline progress. Financial highlights include EUR 4.2M revenue and EUR 81.5M cash balance. CEO Dave Marver highlights successful ARC-EX System launch

Revenue Growth Pipeline Progress ONWARD Medical ARC-EX System First Half 2026 Results
BRIEF

published on 04/20/2026 at 17:54, 4 months 22 days ago

ONWARD Medical clôture un placement privé et lève 40,6 millions d'euros.

Euronext Placement Privé ONWARD Medical Thérapie De La Moelle Épinière Neurotechnologie
BRIEF

published on 04/20/2026 at 17:54, 4 months 22 days ago

ONWARD Medical Concludes Private Placement Raising EUR 40.6M

Private Placement Euronext Neurotechnology ONWARD Medical Spinal Cord Therapy
PRESS RELEASE

published on 04/20/2026 at 17:49, 4 months 22 days ago

ONWARD Medical Publishes Closing of Bookbuild Offering
ONWARD Medical N.V. announces closing of EUR 40.6M Private Placement with institutional investors, new shares listed on Euronext. Company pioneering neurotechnology therapies for spinal cord injuries and movement disabilities

Private Placement Euronext Neurotechnology ONWARD Medical Spinal Cord Injuries
BRIEF

published on 04/16/2026 at 07:39, 4 months 26 days ago

ONWARD Medical Secures Over EUR 40 Million in Capital Increase

EQT Life Sciences Capital Increase Neurotechnology ONWARD Medical Spinal Cord Injuries
BRIEF

published on 04/16/2026 at 07:39, 4 months 26 days ago

ONWARD Medical obtient une augmentation de capital de plus de 40 millions d'euros

Augmentation De Capital ONWARD Medical Neurotechnologie Lésions De La Moelle Épinière EQT Sciences De La Vie
PRESS RELEASE

published on 04/16/2026 at 07:34, 4 months 26 days ago

ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
ONWARD Medical successfully raises over EUR 40 million in capital increase, with EUR 25.0M investment from EQT Life Sciences. Cash runway extended into Q1 2028

EQT Life Sciences Capital Increase Neurotechnology ONWARD Medical Spinal Cord Injuries
BRIEF

published on 04/01/2026 at 08:53, 5 months 11 days ago

ONWARD Medical Convenes 2026 AGM in Amsterdam

Shareholder Resolutions Amsterdam ONWARD Medical AGM 2026 Spinal Cord Therapies

1 2 ... 6

Accesswire

Published on 09/12/2026 at 02:35, 1 day 2 hours ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 6 hours ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 day 7 hours ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 1 day 7 hours ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 12 hours ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 17:50, 11 hours 17 minutes ago

New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 21 hours 37 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 6 hours ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 6 hours ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 9 hours ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

Les Echos

Published on 09/11/2026 at 07:00, 1 day 22 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 22 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 22 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 22 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 9 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE